Mr "Opioid King" and QBLs MMJ = TRUE 25% Up Purdue Pharmas

New Post Public Reply Private Reply Replies (0) Message Board
Ulf53
752
Mr "Opioid King" and QBLs MMJ = TRUE 25% Up Purdue Pharmas former CEO, John Stewart (now President of Emblem Medical) is taking a piece of MCL, subsidiary of QBL. He run (Purdue) one of the largest privately- held Pharma companies in the World. Launched 11 new Products; Oxycontin, Ms Contin and Biphentin absolute Top Sellers Globally.


See Emblem; http://emblemcorp.com/team/


Notice; Emblem management have a big insider post of shares themself.
This is a multi-billion dollar setup - for QBLs subsidiary to be a partner to the BIG BOYS are a incredible story to be continued.


EXTRA ! Now QBLs subsidiary are Selling there HEMP Products on the second largest grocery chain. QBL will get much welcomed Revenue threw this strong sales.


Yesterday QBLs subsidiary got its listing. This is another positive step, who will gain QBLs value. With 55% of it`s subsidairys shares, they are set up for coming revenues from the MMJ sales within 12 weeks or less.



Some helpfull links to save time;

FACEBOOK - Queensland Bauxite Limited, https://www.facebook.com/queenslandbauxitelimited/

Twitter; https://twitter.com/QLDBauxite

Queensland Bauxite Limited,
https://www.queenslandbauxite.com/

QBL on ASX, https://www.asx.com.au/asx/share-price-research/company/QBL

Factsheet,https://docs.wixstatic.com/ugd/1943b6_8e1d784b487147009fea1e39d2012acb.pdf

QBL Media Posts; https://www.queenslandbauxite.com/blog

Stockbrokers; https://www.onlinebrokersaustralia.com.au/stock-broker/

Canntab Therapeutics; http://canntab.ca/

https://www.facebook.com/queenslandbauxitelimited/

Read More: https://investorshangout.com/post/view?id=500...z5D33rC9cO



Read More: https://investorshangout.com/post/view?id=501...z5DJlHBZ3r
Robert
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Growth Projections for the Intravenous Solutions Market

Updated Category News Views 83

Exploring the Intravenous Solutions Market The Intravenous Solutions Market is projected to reach an impressive USD 23.96 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 8.0% over the forecast period from 2024 to 2031. This robust growth is largely attributed to the increasing elderly population and the rising incidences of malnutrition among them. As...

Continue Reading
Analysts Adjust Price Targets for Progressive After Earnings

Updated Category News Views 151

Progressive Corporation Faces Analysts' Revisions After Q3 Results The Progressive Corporation (NYSE: PGR) recently announced its third quarter earnings, which fell short of analysts' expectations. Analysts and investors alike are closely watching how these results will affect the company's future performance. Disappointing Earnings Report In a recent announcement,...

Continue Reading
Golden Ocean Group's Strategic Merger with CMB.TECH Explained

Updated Category News Views 222

Overview of the Merger Golden Ocean Group Limited (NASDAQ: GOGL) has recently engaged in a strategic collaboration with CMB.TECH NV (NYSE: CMBT) that underscores its ambition to enhance its operational capabilities. This significant merger was initially outlined in a stock exchange announcement, illustrating the companies' plans to join forces for greater efficiency and...

Continue Reading
Investigation Launched Into Zions Bancorp's Securities Practices

Updated Category News Views 219

Investigation of Zions Bancorp by Johnson Fistel, PLLP Johnson Fistel, PLLP, a well-respected law firm specializing in shareholder rights, has embarked on an important investigation regarding Zions Bancorporation, N.A. (NASDAQ: ZION). This inquiry focuses on potential violations of federal securities laws which may have affected investors, particularly regarding...

Continue Reading
Planet Fitness Analysts Anticipate Growth Amid Price Increases

Updated Category News Views 240

Anticipated Growth for Planet Fitness Shares of Planet Fitness Inc (NYSE: PLNT) have shown promising activity in early trading, reflecting a potentially strong outlook. The upcoming fourth-quarter earnings report is capturing market attention, as analysts anticipate robust growth driven by strategic pricing adjustments. Price Adjustments and Market Response The increase...

Continue Reading